The MD Anderson manual of medical oncology
著者
書誌事項
The MD Anderson manual of medical oncology
McGraw-Hill, c2011
2nd ed
- : hardcover
大学図書館所蔵 全7件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
A hands-on desk reference for the practicing oncologist - from the leader in the field of cancer management
A 2015 Doody's Core Title!
The MD Anderson Manual of Medical Oncology details the personalized multidisciplinary approach to cancer management pioneered by The University of Texas MD Anderson Cancer Center. It is intended to bring a pragmatic approach to cancer management that can serve as a guide for oncologists around the world.
This completely updated second edition emphasizes and discusses recent developments in diagnostic procedures, which include the incorporation of new molecular markers and revised staging systems. It also reinforces how imaging and molecular profiling can prevent administration of overly aggressive, toxic treatment regimens, or invasive surgery to treat superficial or indolent tumors. Also new to the second edition are special commentaries provided by subspecialists in pulmonary medicine, radiation oncology, and surgery which discuss other perspectives on management.
To help you quickly assess cancer management options, every chapter includes numerous tables, diagrams, and imaging photographs. These include evidence-based treatment algorithms in the form of flowcharts and diagrams shaped by the clinical experience of MD Anderson's world-class faculty. Everything is designed to provide you with a practical guide to diagnostic and therapeutic strategies used at MD Anderson.
The second edition also features important new chapters on key topics such as:
Myelodysplastic syndrome Myeloproliferative neoplasmsT-cell lymphomasSmall bowel and appendiceal cancersInflammatory breast cancer
Offering the perfect balance of narrative text, summary tables, and clinical photographs (many in full color), there is truly not a more accessible, up-to-date, or authoritative clinician's guide to the medical management of patients with cancer and its complications than The MD Anderson Manual of Medical Oncology.
目次
- Contributors Preface Foreword PART I: LEUKEMIA 1. Acute Lymphoblastic Leukemia, Elias Jabbour, Amber Fullmer, Stefan Faderl 2. Adult Acute Myeloid Leukemia, Sameer A. Parikh, Elias Jabbour, Charles A. Koller 3. Chronic Lymphocytic Leukemia and Associated Disorders, Ravin J. Garg, Carlos Bueso-Ramos, Susan O'Brien 4. Chronic Myeloid Leukemia, Naveen Pemmaraju, Sameer A. Parikh, Elias Jabbour, Hagop M. Kantarjian, Jorge Cortes 5. Myelodysplastic Syndromes: The MD Anderson Cancer Center Approach, William S. Stevenson, Carlos Bueso-Ramos, Guillermo Garcia-Manero 6. Philadelphia Chromosome-Negative Myeloproliferative Neoplasms, Nitin Jain, Hesham M. Amin, Srdan Verstovsek PART II: LYMPHOMA AND MYELOMA 7. The Indolent Lymphomas, Peter McLaughlin, Nathan Fowler, Nini Liu, L. Jeffrey Medeiros 8. Aggressive and Highly Aggressive B-cell Lymphomas, Luis E. Fayad, Sergej Konoplev, Hubert H. Chuang, M. Alma Rodriguez
- Commentary: Bouthaina S. Dabaja 9. T-cell Lymphomas, Jenny Pozadzides, Madeleine Duvic, Barbara Pro 10. Hodgkin Lymphoma, Jason Westin, Fredrick B. Hagemeister, Valerie K. Reed, Michelle Fanale 11. Multiple Myeloma and Other Plasma Cell Dyscrasias, Tiffany P. Avery, Nina Shah, Weijun Fu, Donna M. Weber, Gary Lu, Pei Lin, Muzaffar H. Qazilbash, Michael Wong PART III: STEM CELL TRANSPLANTATION 12. Allogeneic Transplantation, Carrie Yuen, Sergio Giralt 13. Autologous Stem Cell Transplantation, Carrie Yuen, Richard E. Champlin PART IV: LUNG CANCER 14. Small Cell Carcinoma of the Lungs, Kathryn A. Gold, Bonnie S. Glisson
- Commentary:Cesar Moran 15. Non-small Cell Lung Cancer, Don Gibbons, Katherine M. Pisters, Faye Johnson
- Commentary: George A. Eapen PART V: HEAD AND NECK CANCER 16. Head and Neck Cancer, Eric S. Kim, G. Brandon Gunn, William Nassib William Jr., Merrill S. Kies PART VI: GASTROINTESTINAL CARCINOMAS 17. Gastric and Esophageal Cancer, Alexandria T. Phan 18. Pancreatic Cancer, Rachna T. Shroff, Robert A. Wolff, Milind M. Javle 19. Hepatobiliary Malignancies, Nishin A. Bhadkamkar, Milind M. Javle, Rony Avritscher, Sunil Krishnan, Ahmed O. Kaseb 20. Small Bowel Cancer and Appendiceal Tumors, Michael J. Overman, Christopher Lieu
- Commentary: Keith F. Fournier 21. Colorectal Cancer, Nishin Bhadkamkar, Christopher H. Crane, Miguel Rodriguez-Bigas
- Scott Kopetz
- Cathy Eng 22. Anal Cancer, Tzu-chuan Jane Huang, Cathy Eng
- Commentary: Christopher H. Crane 23. Neuroendocrine Tumors, John Andrew Jakob, Carlo M. Contreras, Bruno C. Odisio, Sanjay Gupta, Eddie K. Abdalla, James C. Yao PART VII: BREAST CANCER 24. Early-Stage and Locally Advanced Breast Cancer, Sapna P. Patel, Aman U. Buzdar
- Commentary: Kelly K. Hunt 25. Metastatic Breast Cancer, Mariana Chavez-MacGregor, Vicente Valero 26. Inflammatory Breast Cancer, Windy Marie Dean-Columb, Massimo Cristofanilli 27. Special Situations in Breast Cancer, Rachel L. Theriault, Karin M.E. Hahn PART VIII: GYNECOLOGIC MALIGNANCIES 28. Ovarian Cancer, Bryan T. Hennessy, Grace K. Suh, Maurie Markman 29. Tumors of the Uterine Corpus, Grace K. Suh, Bryan T. Hennessy, Maurie Markman 30. Tumors of the Uterine Cervix, Pedro T. Ramirez, Maria Jimena Lange, John J. Kavanagh, Alexandria T. Phan, Siriwan Tangjitgamol 31. Gestational Trophoblastic Tumors, Maurie Markman, John J. Kavanagh PART IX: GENITOURINARY CARCINOMA 32. Renal Cell Carcinoma, Eric Jonasch, Surena F. Matin, Lance C. Pagliaro, Christopher G. Wood, Nizar M. Tannir 33. Bladder Cancer, Arlene O. Siefker-Radtke, Colin P.N. Dinney, Dogdan A. Czerniak, Randall E. Millikan
- Commentary: David J. McConkey 34. Prostate Cancer, Paul Corn, Christopher Logothetis 35. Penile Cancer, Lance C. Pagliaro 36. Germ Cell Tumors, Heather D. Brooks, Lance C. Pagliaro, Zita Dubauskas Lim, Louis L. Pisters, Nizar M. Tannir PART X: MISCELLANEOUS TUMORS 37. Tumors of the Central Nervous System, Nicole A. Shonka, Sigmund H. Hsu, W.K. Alfred Yung
- Commentary: Anita Mahajan, Sujit Prabhu 38. Endocrine Malignancies, Naifa Lamki Busaidy, Mouhammed Amir Habra, Rena Vassilopoulou-Sellin 39. Malignant Melanoma, Kevin B. Kim, Michael A. Davies, Ronald P. Rapini, Patrick Hwu, Agop Y. Bedikian 40. Soft Tissue and Bone Sarcomas, Anthony Conley, Min S. Park, Jonathan C. Trent, Shreyaskumar Patel 41. The AIDS-related Cancers, Adan Rios, Fredrick B. Hagemeister 42. Carcinoma of Unknown Primary, Gauri R. Varadhachary PART XI: SUPPORTIVE CARE 43. Infection in the Neutropenic Patient, Kenneth V.I. Rolston 44. Fungal and Viral Infections in Cancer Patients, Bruno P. Granwehr, Roy F. Chemaly, Dimitrios P. Kontoyiannis
- Commentary: Jeffrey J. Tarrand 45. Endocrine and Metabolic Complications of Cancer Therapy, Mouhammed Amir Habra, Naifa Lamki Busaidy, Sai-Ching Jim Yeung, Rena Vassilopoulou-Sellin 46. Oncologic Emergencies, Sai-Ching Jim Yeung, Ellen F. Manzullo PART XII: PALLIATIVE CARE AND SYMPTOM MANAGEMENT 47. Defining Palliative Care in Oncology, Jessica Masterson, Michael J. Fisch
- Commentary: Jeffrey E. Lee 48. Pain Management and Symptom Control, Suresh K. Reddy, Gabriel Lopez, Ahmed Elsayem PART XIII: LONG-TERM SURVIVAL 49. Pediatric Long-Term Follow-up, Joann I. Ater, Norman Jaffe, Nita R. Burrer 50. Adult Long-Term Follow-up, Pamela N. Schultz, Charles J. Stava, Mouhammad Amir Habra, Rena Vassilopoulou-Sellin 51. Rehabilitation, Jack Fu, Ki Y. Shin Index
「Nielsen BookData」 より